Correction: Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy

20250 citationserratumgold Open Access

Authors

Good health and well-being

Published in: PharmacoEconomics - Open

Volume 9, Issue 6, pp. 1009-1009

Field-Weighted Citation Impact: 0.00